A cyclooxygenase-2 inhibitor, nimesulide, inhibits postinitiation phase of N-nitrosobis(2-oxopropyl)amine-induced pancreatic carcinogenesis in hamsters

International Journal of Cancer

Volumn 104, Issue 3, 2003, Pages 269-273

  Furukawa, Fumio ^a   Nishikawa, Akiyoshi ^a   Lee, In Seon ^b   Kanki, Keita ^a   Umemura, Takashi ^a   Okazaki, Kazushi ^a   Kawamori, Toshihito ^c   Wakabayashi, Keiji ^c   Hirose, Masao ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^b Keimyung University   (South Korea)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Hamster; N nitrosobis(2 oxopropyl)amine; Nimesulide; Pancreatic carcinogenesis

Indexed keywords

BIS(2 OXOPROPYL)NITROSAMINE; CYCLINE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; NIMESULIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT CARCINOMA; CARCINOGENESIS; CONTROLLED STUDY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KIDNEY TUMOR; LIVER CELL CARCINOMA; LUNG TUMOR; MALE; NONHUMAN; PANCREAS ADENOCARCINOMA; PANCREAS ISLET CELL HYPERPLASIA; PRECANCER; PRIORITY JOURNAL; SYRIAN HAMSTER;

ADENOCARCINOMA; ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CRICETINAE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DISEASE PROGRESSION; ISOENZYMES; MALE; MESOCRICETUS; NITROSAMINES; PANCREATIC NEOPLASMS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SULFONAMIDES;

EID: 0037431436     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10965     Document Type: Article

References (36)

1. Yamamoto M, Ohashi O, Saitoh Y. Japan Pancreatic Cancer Registry: current status. Pancreas 1998;16:238-42.
2. Stephens J, Kuhn J, O'Brien J, Preskitt J, Derrick H, Fisher T, Fuller R, Lieberman Z. Surgical morbidity, mortality, and long-term survival in patients with peripancreatic cancer following pancreaticoduodenectomy. Am J Surg 1997;174:600-3.
3. Williams CS, DuBois RN. Prostaglandin endoperoxide synthase: why two isoforms? Am J Physiol 1996;270:G393-400.
4. Fosslien E. Biochemistry of cyclooxygenase (COX-2) inhibitors and molecular pathology of COX-2 in neoplasia. Crit Rev Clin Lab Sci 2000;37:431-502.
5. Sano H, Kawahito Y, Wilder RL, Hashiramoto A, Mukai S, Asai K, Kimura S, Kato H, Kondo M, Hla T. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res 1995;55:3785-9.
6. Ristimaki A, Honkanen N, Jankala H, Sipponen P, Harkonen M. Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res 1997;57:1276-80.
7. Shiota G, Okubo M. Noumi T, Noguchi N, Oyama K, Takano Y, Yashima K, Kishimoto Y, Kawasaki H. Cyclooxygenase-2 expression in hepatocellular carcinoma. Hepatogastroenterology 1999;46:407- 12.
8. Wolff H, Saukkonen K, Anttila S, Karjalainen A, Vainio H, Ristimaki A. Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res 1998;58:4997-5001.
9. Okami J, Yamamoto H, Fujiwara Y, Tsujie M, Kondo M, Noura S. Overexpression of cyclooxygenase-2 in carcinoma of the pancreas. Clin Cancer Res 1999;5:2018-24.
10. Maitra A, Ashfaq R, Gunn CR, Rahman A, Yeo CJ, Sohn TA, Cameron JL, Hruban RH, Wilentz RE. Cyclooxygenase 2 expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia: an immunohistochemical analysis with automated cellular imaging. Am J Clin Pathol 2002;118:194-201.
11. Herschman HR. Regulation of prostaglandin synthase-1 and prostaglandin synthase-2. Cancer Metastasis Rev 1994;13:241-56.
12. Zhang MZ, Wang JL, Cheng HF, Harris RC, McKanna JA. Cyclo-oxygenase-2 in rat nephron development. Am J Physiol 1997;273: F994-1002.
13. Tsujii M, DuBois RN. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthesis 2. Cell 1995;83:493-501.
14. Tsujii M, Kawano S, DuBois RN. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA 1997;94:3336-40.
15. 2 down-regulates the expression of HLA-DR antigen in human colon adenocarcinoma cell lines. Biochemistry 1995;34:5604-9.
16. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN. Cyclooxygenase regulaters angiogenesis induced by colon cancer cells. Cell 1998;93:705-16.
17. Kotsinas A, Gorgoulis V, Zacharatos P, Zioris H, Triposkiadis F, Dontal I, Kyriakidis M, Karayannacos P, Kittas C. Antioxidant agent nimesulide and beta-blocker metoprolol do not exert protective effects against rat mitochondrial DNA alterations in Adriamycin-induced cardiotoxicity. Biochem Biophys Res Commun 1999;254:651-6.
18. Takahashi M, Fukutake M, Yokota S, Ishida K. Wakabayashi K, Sugimura T. Suppression of azoxymethane-induced aberrant crypt foci in rat colon by nimesulide, a selective inhibitor of cyclooxygenase 2. J Cancer Res Clin Oncol 1996;122:219-22.
19. Fukutake M, Nakatsugi S, Isoi T, Takahashi M, Ohta T, Mamiya S, Taniguchi Y, Sato H, Fukuda K, Sugimura T, Wakabayashi K. Suppressive effect of nimesulide, a selective inhibitor of cyclooxygenase-2, on azoxymethane-induced colon carcinogenesis in mice. Carcinogenesis 1998;19:1939-42.
20. Nakatsugi S, Ohta T, Kawamori T, Mutoh M, Tanigawa T, Watanabe K, Sugie S, Sugimura T, Wakabayashi K. Chemoprevention by nimesulide, a selective cyclooxygenase-2 inhibitor, of 2-amino-l-methyl-6-phenylimidazo[4,5-b]pryridine (PhIP) induced mammary gland carcinogenesis in rats. Jpn J Cancer Res 2000;91:886-92.
21. Shiotani H, Denda A, Yamamoto K, Kitayama W, Endoh T, Sasaki Y, Tsutsumi N, Sugimura M, Konishi Y. Increased expression of cyclooxygenase-2 protein in 4-nitroquinoline l-oxide-induced rat tongue carcinomas and chemopreventive efficacy of a specific inhibitor, nimesulide. Cancer Res 2001;61:1451-6.
22. Okajima E, Denda A, Ozono S, Takahama M, Akai H, Sasaki Y, Kitayama W, Wakabayashi K, Konishi Y. Chemopreventive effects of nimesulide, a selective cyclooxygenase-2 inhibitor, on the development of rat urinary bladder carcinomas initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine. Cancer Res 1998;58:3028-31.
23. Takahashi M, Furukawa F, Toyoda K, Sato H, Hasegawa R, Imaida K, Hayashi Y. Effects of various prostaglandin synthesis inhibitors on pancreatic carcinogenesis in hamsters after initiation with N-nitrosobis(2-oxopropyl)amine. Carcinogenesis 1990;11:393-5.
24. Pour P, Althoff J, Krüger FW, Mohr U. A potent pancreatic carcinogen in Syrian golden hamsters: N-nitrosobis(2-oxopropyl)amine. J Natl Cancer Inst 1977;58:1449-53.
25. Nishikawa A, Furukawa F, Imazawa T, Yoshimura H, Mitsumori K, Takahashi M. Effects of caffeine, nicotine, ethanol and sodium selenite on pancreatic carcinogenesis in hamsters after initiation with N-nitrosobis(2-oxopropyl)amine. Carcinogenesis 1992;13:1379-82.
26. Furukawa F, Nishikawa A, Imaida K, Mitsui M, Enami T, Hayashi Y, Takahashi M. Inhibitory effects of crude soybean trypsin inhibitor on pancreatic ductal carcinogenesis in hamsters after initiation with N-nitrosobis(2-oxopropyl)amine. Carcinogenesis 1992;13:2133-5.
27. Nishikawa A, Furukawa F, Uneyama C, Ikezaki S, Tanakamaru Z, Chung F-L, Takahashi M, Hayashi Y. Chemopreventive effects of phenethyl isothiocyanate on lung and pancreatic tumorigenesis in N-nitrosobis(2-oxopropyl)amine-treated hamsters. Carcinogenesis 1996;17:1381-4.
28. Banerjee S, Bueso-Ramos C, Aggarwal BB. Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-kappaB, cyclooxygenase 2, and matrix metalloprotease 9. Cancer Res 2002;62:4945-54.
29. Nishikawa A, Lee IS, Uneyama C, Furukawa F, Kim HC, Kasahara K, Huh N, Takahashi M. Mechanistic insights into chemopreventive effects of phenethyl isothiocyanate in N-nitrosobis(2-oxopropyl)amine-treated hamsters. Jpn J Cancer Res 1997;88:1137-42.
30. Anderson KE, Johnson TW, Lazovich D, Folsom AR. Association between nonsteroidal anti-inflammatory drug use and the incidence of pancreatic cancer. J Natl Cancer Inst 2002;94:1168-71.
31. Nakatsugi S, Terada N, Yoshimura T, Horie Y, Furukawa M. Effects of nimesulide, a preferential cyclooxygenase-2 inhibitor, on carcinogen-induced pleurisy and stress-induced gastric lesions in rats. Prostaglandins Leukot Essent Fatty Acids 1996;55:395-402.
32. Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 1996;87:803-9.
33. Kawamori T, Rao CV, Seibert K, Reddy BS. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res 1998;58:409-12.
34. Kawamori T, Uchiya N, Kitamura T, Ohuchida S, Yamamoto H, Maruyama T, Sugimura T, Wakabayashi K. Evaluation of a selective prostaglandin E receptor EP1 antagonist for potential properties in colon carcinogenesis. Anticancer Res 2001;21:3865-9.
35. Koliopanos A, Friess H, Kleeff J, Roggo A, Zimmermann A, Buchler MW. Cyclooxygenase 2 expression in chronic pancreatitis: correlation with stage of the disease and diabetes mellitus. Digestion 2001;64:240-7.
36. Shibata MA, Hasegawa R, Imaida K, Hagiwara A, Ogawa K, Hirose M, Ito N, Shirai T. Chemoprevention by dehydroepiandrosterone and indomethacin in a rat multiorgan carcinogenesis model. Cancer Res 1995;55:4870-4.